Glatiramer acetate (also known as Copolymer 1, Cop-1), sold under the brand name Copaxone among others, is an immunomodulator medication used to treat...
20 KB (1,904 words) - 04:01, 14 April 2024
modestly effective at decreasing the number of attacks. Interferons and glatiramer acetate are first-line treatments and are roughly equivalent, reducing relapses...
167 KB (17,789 words) - 00:41, 10 July 2024
beta-1a and beta-1b (injections) Three generic immunomodulators: Glatiramer acetate (Copaxone, injection) Teriflunomide (Aubagio), Monomethyl fumarate...
83 KB (9,414 words) - 17:06, 8 June 2024
ocrelizumab, ofatumumab, and ublituximab; and immunomodulators: glatiramer acetate, mitoxantrone, fingolimod, teriflunomide, dimethyl fumarate, and diroximel...
131 KB (14,018 words) - 08:00, 24 June 2024
the treatment of asthma and COPD. GA Depot (long-acting version of glatiramer acetate): In August 2023, received New Drug Application acceptance from the...
23 KB (1,914 words) - 02:25, 26 June 2024
patients ultimately discontinue taking interferons [citation needed] (or glatiramer acetate, a comparable disease-modifying therapy requiring regular injections)...
30 KB (2,727 words) - 19:16, 6 April 2024
with marketing partner Alvogen, multiple sclerosis treatment drug glatiramer acetate in partnership with Mylan, and hepatitis C drugs under a licensing...
6 KB (450 words) - 12:43, 28 June 2024
Betaseron competes with other injectable forms of interferon beta, glatiramer acetate, and a variety of newer multiple sclerosis drugs, some of which can...
119 KB (11,417 words) - 17:40, 3 July 2024
exactly which cells produce IL-1β. Treatment of multiple sclerosis with glatiramer acetate or natalizumab has also been shown to reduce the presence of IL-1β...
26 KB (3,305 words) - 06:50, 28 March 2024
Current treatments for multiple sclerosis include interferon-B, Glatiramer acetate, and Mitoxantrone, which function by reducing or inhibiting T Cell...
44 KB (5,084 words) - 09:14, 11 February 2024